Many studies have identified the association between severe COVID-19 and heightened platelet activation [3] as well as deficient interferon (IFN)-α levels have been also associated with increased interleukin (IL)-10 expression in patients progressing to severe or life-threatening COVID-19 conditions [4]. This evidence concerns the gene IL10 and COVID-19.